ACTU

Conviction 0HealthcareScan · Mon, Aug 10, 2026

ACTU$1.01-8.60%

ResistanceSupportVol 14

Vol MA14 194.06K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ACTUATE THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.actuatetherapeutics.com ↗

Price1.01

Change-8.60%

Gap+0.45%

Rel volume0.93×

Avg volume315.76K

Avg $ vol456.06K

SMA 201.26

SMA 501.57

SMA 2003.80

Price vs 50-35.70%

Price vs 200-73.45%

MA stackbearish

50/200 cross—

Supertrenddown · 1.51

RSI (14)35

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D1 / 20

ADX (14)15

+DI / −DI16 / 23

RSI divergence—

MACD divergence—

ATR %+16.43%

ADR %12.02%

52w high8.72

52w low1.01

From 52w high-88.42%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width68.67%

%B0.21

Donchian pos0.53%

Donchian high1.95

Donchian low1.01

AVWAP (52w high)3.19

vs AVWAP high-68.29%

AVWAP (52w low)1.04

vs AVWAP low-3.04%

OBV trendUp

Chaikin MF (20)-0.12

Today vs 20d0.93×

Avg vol (14d)194.06K

Avg vol (20d)315.76K

Avg $ vol (20d)456.06K

Market cap24.17M

RS 3m (vs SPY)-72.61%

RS 6m (vs SPY)-88.54%

RS line new highNo

Trend template0/8

Technical rank2.1

1 week-4.72%

1 month-16.53%

3 months-69.39%

6 months-77.10%

1 year-87.48%

YTD-83.25%

P/E-1.09

P/B6.39

P/S—

P/FCF—

EPS-1.06

Div yield—

ROE-587.36%

ROA-249.43%

Debt/Eq—

Current1.80

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth18.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value16.03M

Revenue—

Net income-5.63M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out23.93M

Employees12

ListedTue, Aug 13, 2024

Free float9.54M

Float %40.3%

Short interest754.75K

Days to cover1.0d

Short volume81.3%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank2.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.14

Support1.03

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACTU

All disclosures →

No recent disclosed trades by Congress in ACTU. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACTU · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Fletcher Aaron G.L. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Zabrowski Dan Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
RONNEBERG AMY L Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
THOMSON TODD S Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Huber Martin H. Jr. Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Keyes Jason A Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22
Sawhney Roger Director · Stock Options · 2026-05-21	Grant	15K	$0	2026-05-21	2026-05-22

SEC filings

EDGAR filings in ACTU · 1 recent

EDGAR →

8-K8-KDelisting riskFri, Jul 17, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.